(D-Phe2'6,Pro3)-LHRH, also known as a synthetic analog of Luteinizing Hormone-Releasing Hormone (LHRH), is a peptide that plays a crucial role in the regulation of reproductive hormones. This compound is characterized by its specific amino acid sequence, which includes D-phenylalanine at positions 2 and 6, and proline at position 3, contributing to its stability and biological activity. The modifications in its structure enhance its resistance to enzymatic degradation, making it more effective in therapeutic applications. Typically, this peptide functions by binding to LHRH receptors, stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. Its applications are primarily in the fields of endocrinology and reproductive medicine, particularly in the treatment of hormone-sensitive conditions such as prostate cancer and endometriosis. The compound's pharmacokinetic properties, including its half-life and bioavailability, are influenced by its peptide nature, which is crucial for its therapeutic efficacy.

(D-Phe2'6,Pro3)-LHRH

67019-15-2: (D-Phe2'6,Pro3)-LHRH, also known as a synthetic analog of Luteinizing Hormone-Releasing Hormone (LHRH), is a peptide that plays a crucial role in the regulation of reproductive hormones. This compound is characterized by its specific amino acid sequence, which includes D-phenylalanine at positions 2 and 6, and proline at position 3, contributing to its stability and biological activity. The modifications in its structure enhance its resistance to enzymatic degradation, making it more effective in therapeutic applications. Typically, this peptide functions by binding to LHRH receptors, stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the pituitary gland. Its applications are primarily in the fields of endocrinology and reproductive medicine, particularly in the treatment of hormone-sensitive conditions such as prostate cancer and endometriosis. The compound's pharmacokinetic properties, including its half-life and bioavailability, are influenced by its peptide nature, which is crucial for its therapeutic efficacy.

<p>Please enquire for more information about (D-Phe2·6,Pro3)-LHRH trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

CAS 67019-15-2

(D-Phe2'6,Pro3)-LHRH

(D-Phe2·6,Pro3)-LHRH trifluoroacetate salt

Ref: 3D-FP109159